Furthermore, future mechanistic studies could enhance the understanding of the role of sPD-1 as a pivotal factor in the early immune dysregulation stage during preclinical type 1 diabetes before disease progression. The gene discussed is HOXD13; the disease is type 1 diabetes mellitus.